Myriad Genetics, Inc.’s MYGN Oncology growth strategy, which focuses on expanding companion diagnostics and market growth through new clinical guidelines, is poised to drive growth in the upcoming ...

Abramorama announced that it has acquired U.S. distribution rights to RadicalMedia’s production of Jake Sumner’s ...

Billionaire Mukesh Ambani’s Reliance Industries Ltd, through its wholly owned subsidiary Jio Financial Services Ltd (JFSL), ...

Japanese researchers used a nonviral piggyBac system to genetically modify cynomolgus monkeys, enabling more accurate disease ...

DelveInsight's "LUXTURNA Market Size, Forecast, and Market Insight Report" highlights the details around LUXTURNA, a one-time ...

(NYSE: CALX) announces it has ranked 11th on the Fast Company 2025 list of the World's Most Innovative Companies in enterprise. This achievement highlights the broad recognition Calix continues to ...

Researchers successfully use a nonviral, piggyBac transposon system to introduce a transgene into cynomolgus monkeys.

For organs to develop, grow and regenerate, cells must proliferate. But when that process goes awry, leading to uncontrolled cell growth, cancer can emerge.

Genetic engineering in non-human primates has long been limited by the need for virus-based gene delivery methods. Recently, ...

MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.

Genetic engineering in non-human primates has long been limited by the need for virus-based gene delivery methods. Recently, ...